DJ Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ shed 1.55% to $1.27 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.12% to 26,370.89 and Dow Jones Industrial Average falling 0.70% to 53,185.90.
Inovio Pharmaceuticals Inc. closed 57.37% short of its 52-week high of $2.98, which the company reached on September 9th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.82% to $265.85, Statera Biopharma Inc. (STAB) rose 100.00% to $0.00, and Pfizer Inc. $(PFE)$ rose 1.79% to $28.46.
Trading volume (5.6 M) eclipsed its 50-day average volume of 3.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 31, 2026.
Comments